BLLN BillionToOne Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
16:01
Aug 05
Aug 05
Watch BLLN continuing its ripper.
Watch BLLN because it is continuing a strong upside run, but no position or explicit buy call is disclosed in the post.
MED
13:54
Jun 22
Jun 22
Founders explain hard science, overachieve.
Sandy found BillionToOne through the short-lived YC Fellowship and backed it pre-seed, then doubled down and made it his largest angel investment, including at a $4 million valuation. He was impressed by three brilliant PhD founders who were raw, honest, not bullshitters, and able to explain highly technical biology to a non-expert. They were intellectually honest about risks, overachieved repeatedly, and built a profitable diagnostics business with NIPT and liquid biopsy, reaching roughly a $400 million revenue run rate with 100% growth.
HIGH
23:49
May 14
May 14
Buy Billion to One stock.
Billion to One is a real diagnostics company. Despite a silly name, the company has potential and Jim Cramer says 'BUY IT'.
MED
23:54
Apr 27
Apr 27
Billion to One is a winner
Billion to One is a good diagnostic company; despite sector weakness, the stock hasn't run and is a winner.
MED
About BLLN Investor Commentary
Across the available history and selected sources, Buzzberg tracks BLLN (BillionToOne) across 3 sources: 3 bullish vs 0 bearish calls from 3 authors. Historical directional balance: 75% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 4 total trade ideas tracked. Latest voices: Avi Felman, Sandy Kory, Jim Cramer.